TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT01117662

Efficacy of Rituximab in Acute Cellular Rejection in Renal Transplant Patients

Cause of deathSlow enrollment Automatic label, confidence 0.5, unverified. How labels are made.
“The planned recruitment number of 180 Patient could not been achieved.”

The sponsor’s own words in the registry.

Life of this trial

20102011201220132014201520162017Registered2010-04-28Started2012-05Primary completion2016-05Stopped2016-08-23

Vital statistics

Status
Terminated
Phase
Phase 3
Sponsor
Hannover Medical School
Sponsor type
University, hospital or other
Conditions
Acute Rejection
Interventions
Rituximab; Placebo
Participants
13
Sites
14
Countries
Germany

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.